Search the Newsreel

Legal & General reports 4.9% Ziff Davis (ZD) ownership position

Legal & General Group Plc and its affiliated investment entities have reported a 4.9% beneficial ownership in Ziff Davis, Inc., amounting to 1,800,921 shares as of June 30, 2026. This ownership is held with shared voting and dispositive power across various asset management affiliates …

Annovis Bio Sees Unusually Large Options Volume (NYSE:ANVS)

Annovis Bio (NYSE:ANVS) experienced unusual options trading volume on Friday, with traders buying 3,595 put options, a 139% increase over its typical daily volume. Despite a "Moderate Buy" consensus rating from analysts, the stock is trading near its 52-week low. The company recently reported …

Can NVST Sustain Its 2026 Guidance Boost as Margins Keep Expanding?

Envista Holdings Corporation NVST raised its 2026 outlook after a stronger first half, putting greater emphasis on whether recent sales and profit gains can carry through the rest of the year. Higher revenue expectations and expanding margins support the earnings recovery. China pricing changes, …

MicroVision Prices $17 Million Public Offering to Fund Operations and Capital Spending

MicroVision, Inc. (Nasdaq: MVIS) has priced a $17 million public offering consisting of 6.8 million units, each unit comprising one share of common stock and one warrant. This financing aims to provide capital for working capital, capital expenditures, and general corporate purposes as the …

Envision Greenwise Sets Auditor Reappointment and Fee Range Ahead of AGM

Implied Volatility Surging for Banco Bilbao Stock Options

Implied volatility for Banco Bilbao Vizcaya Argentaria, S.A. (BBVA) stock options, particularly the Sept. 18, 2026 $25.00 Call, is surging, indicating that the market anticipates a significant price movement. Despite this, analysts currently rate Banco Bilbao as a Zacks Rank #4 (Sell), suggesting a …

MicroVision prices $17M public offering at $2.50 per unit

MicroVision, Inc. has announced the pricing of a public offering consisting of 6,800,000 units at $2.50 per unit, aiming to raise approximately $17.0 million in gross proceeds. Each unit includes one share of common stock and one warrant, exercisable at $2.50 per share for …

MicroVision Announces Pricing of $17.0 Million Public Offering

MicroVision, Inc. has announced the pricing of a public offering of 6,800,000 units at $2.50 per unit, aiming to raise approximately $17.0 million in gross proceeds. Each unit consists of one share of common stock and one warrant to purchase another share. The company …

Royal Bank of Canada Grows Position in Visteon Corporation $VC

Royal Bank of Canada significantly increased its stake in Visteon Corporation (NASDAQ:VC) by 103.2% in the first quarter, now owning 45,410 shares valued at $4.14 million. This move comes as institutional investors collectively hold 99.71% of Visteon's stock. Despite missing quarterly EPS estimates, the …

American Century group discloses 11.8% Entravision (EVC) stake in amended report

An amended Schedule 13G/A filing reveals that American Century Investment Management, Inc., American Century Companies, Inc., and the Stowers Institute for Medical Research collectively hold an 11.8% beneficial stake in Entravision Communications Corporation (EVC), totaling 9,791,525 shares. American Century Capital Portfolios, Inc. separately holds …

Vistagen reports Q1 FY2027: $1.48M revenue, $13.0M net loss, $31.7M cash at June 30, 2026

Vistagen announced its Q1 FY2027 results, reporting $1.476 million in revenue and a net loss of $13.03 million. The company ended the quarter with $31.7 million in cash, expecting these funds to support operations into 2027. Vistagen also highlighted upcoming FDA discussions regarding a …

Form 8K VistaGen Therapeutics Inc For: 14 August By Investing.com

This article announces that VistaGen Therapeutics Inc. has filed a Form 8K on August 14th. The brief news item from Investing.com provides no further details about the content of the filing but notes the stock symbol VTGN.

Vistagen Reports Fiscal Year 2027 First Quarter Financial Results and Corporate Update

Vistagen announced its fiscal year 2027 first-quarter financial results, highlighting progress in its fasedienol program for social anxiety disorder, including plans for FDA engagement regarding a Phase 3 pathway. The company reported a net loss of $13.0 million, reduced R&D and G&A expenses due …

VistaGen Therapeutics GAAP EPS of -$0.30 beats by $0.06, revenue of $1.48M beats by $1.31M

* VistaGen Therapeutics press release [https://seekingalpha.com/pr/20619736-vistagen-reports-fiscal-year-2027-first-quarter-financial-results-and-corporate-update] (VTGN [https://seekingalpha.com/symbol/VTGN]): Q1 GAAP EPS of -$0.30 beats by $0.06. * Revenue of $1.48M (+516.7% Y/Y) beats by $1.31M. * Cash, cash equivalents, and marketable securities were $31.7 million as of June 30, 2026. Based on current operating …

Annovis expects October study to let Alzheimer’s patients continue treatment

Annovis (NYSE: ANVS) reported Q2 2026 results, highlighting that its pivotal Phase 3 early Alzheimer’s trial is fully enrolled with 850 patients and an open-label extension for Alzheimer's patients is planned for October 2026. The company also provided updates on its Parkinson's open-label extension, …

Annovis Provides Corporate Updates and Second Quarter 2026 Financial Results

Annovis Bio, Inc. announced significant clinical advancements and its second-quarter 2026 financial results. The company has fully enrolled its pivotal Phase 3 Alzheimer's disease trial with 850 patients, exceeding original projections, and is progressing with its Parkinson's disease open-label extension study. Annovis plans to …

BBVA stock holds near recent highs as half-year profit sets a new record

BBVA stock is trading near its recent highs after the bank reported a record €6.051 billion net profit for the first half of 2026, an 11% increase year-over-year. The company also raised its return-on-tangible-equity target to 21% for the full year. Despite a consensus …

Asian Pay Television Trust (SGX:S7OU) Stock Drifts As Profit Recovery Meets Cord Cutting Risk

Vista Energy (VIST) buys back 50,000 Series A shares for MXN 56.7M

Vista Energy, S.A.B. de C.V. (VIST) announced the repurchase of 50,000 Series A shares on August 13, 2026, for approximately MXN 56.7 million, excluding fees and VAT. The shares were bought back at a price of MXN 1,133.76 per share under an authorization from …

Assenagon Asset Management S.A. Makes New Investment in Vishay Precision Group, Inc. $VPG

Assenagon Asset Management S.A. has initiated a new position in Vishay Precision Group (VPG), acquiring 18,144 shares valued at approximately $2.72 million. This investment comes amidst mixed analyst sentiment for VPG, which holds a "Moderate Buy" consensus rating but recently reported earnings and revenue …

5 Insightful Analyst Questions From Envista’s Q2 Earnings Call

5 Insightful Analyst Questions From Envista's Q2 Earnings Call Envista's second quarter results were shaped by balanced growth across all major geographies and a continued focus on operational execution. Management pointed to resilient demand for dental care, especially in consumables and diagnostics, as a …

Sri Havisha Q1 Results: Board approves unaudited financials

Vishnu Chemicals Share Price Target 2027 to 2030: Analyst Outlook

Jiangsu New Vision Sets August Board Meeting to Approve Interim Results

Shandong Extreme Vision Sets Board Meeting to Approve Interim Results

National Vision Holdings, Inc. (NASDAQ:EYE) Receives Consensus Recommendation of "Moderate Buy" from Brokerages

National Vision Holdings, Inc. (NASDAQ:EYE) has received a "Moderate Buy" consensus rating from brokerages, with an average 12-month price target of $30.36, significantly above its current trading price. The company recently surpassed quarterly earnings and revenue estimates, reporting $0.25 EPS against an $0.18 consensus …

How Investors May Respond To Envista Holdings (NVST) Earnings Rebound And Aggressive Share Buybacks

clearvise AG AKTIE | Aktienkurs & News | A1EWXA – boerse.de

MicroVision announces public offering of common stock units

MicroVision, Inc. (NASDAQ:MVIS) has announced a public offering of units, each consisting of one share of common stock (or a pre-funded warrant) and one warrant to purchase a common stock share. The offering's completion, size, and terms are subject to market conditions, with WestPark …

Ziff Davis (ZD) Q2 2026 Earnings Call Transcript

Image source: The Motley Fool. DATE Aug. 7, 2026 at 8:30 a.m. ET CALL PARTICIPANTS Chief Financial Officer - Bret RichterChief Executive Officer - Vivek Shah TAKEAWAYS Revenue -- $286.7 million, representing a 2.7% decrease across four reportable segments compared to the prior year.Adjusted …

National Vision Holdings (EYE) Raised Its Outlook, Is It Still 35% Undervalued?

Vishwaraj Sugar Industries reports standalone net loss of Rs 25.84 crore in the June 2026 quarter

Onelife Capital Advisors reports standalone net profit of Rs 1.76 crore in the June 2026 quarter

Ziff Davis CAO Lori Tansley sells $76,664 in company stock

Lori A. Tansley, Chief Accounting Officer at Ziff Davis, Inc. (NASDAQ:ZD), sold 1,400 shares of company stock for $76,664 on August 12, 2026. This insider sale occurred while Ziff Davis stock was trading near its 52-week high, following an 83% surge in the past …

CapsoVision Reports Q2 2026 Financials: Inventory Growth and Balance Sheet Update

CapsoVision, Inc. has released its Q2 2026 financial results, highlighting significant inventory growth, increased total assets, and a decrease in cash and cash equivalents. The medical device firm, classified as a non-accelerated filer, reported 50,046,913 shares outstanding and provided forward-looking statements regarding its operations …

Visagar Polytex reports standalone net loss of Rs 0.39 crore in the June 2026 quarter